Shares Investor Evenings showcase up to four presentations from leading companies bringing them together in one room for one evening only.

Directors present their latest plans regarding development and growth

An opportunity to talk directly to the companies and personally put forward your questions

The chance to network with other attendees over drinks and canapés - private investors, wealth managers, private client brokers, fund managers and financial institutions


WHO SHOULD ATTEND?

The evening exposes investors to companies that exhibit growth potential within dynamic industries. Perfect for existing investors as well as those looking for new investment opportunities.

Date:

Tuesday 10th June 2014

Venue:

Novotel Tower Bridge, 10 Pepys Street, London EC3N 2NR

Evening timings:

18:00 - 18:30 Registration and coffee

18:30 - 20:30 Presentations

20:30 - 21:30 Drinks reception and canapés



Attendance is complimentary, but spaces are limited. Register now to secure your place!



Inland Homes

(AIM:INL)

logoInland Homes plc (INL) is a leading brownfield regeneration specialist. We specialise in buying brownfield sites and enhancing their value through obtaining planning permissions for residential and mixed use developments.

Inland's highly experienced land team has extensive knowledge of the complexities of the planning system which in turn enables it to unlock added value in property that others cannot.

We recognise the significant impact our activities can have on the environment and the communities in which we work.

We believe that managing these activities responsibly brings long term benefits to our shareholders as well as our stakeholders.

At the heart of our business is the principle of sustainability- the need to conserve scarce resources for the benefit of future generations.

Sustainability is at the heart of everything we do.

Speakers: Stephen Wicks, CEO and Nish Malde, Finance Director
Valirx

(AIM:VAL)

valirxValirx plc is a biopharmaceutical company developing technologies and products in oncology therapeutics and diagnostics.

Speaker: Satu Vainikka, CEO



Supported by:



DRESS CODE: Business attire

REGISTER NOW